Novel cell-penetrating peptide targeting mitochondria

Area of Science:

• Biochemistry
• Cell Biology
• Medicinal Chemistry

Background:

• Cell-penetrating peptides (CPPs) facilitate the delivery of various cargoes into cells.
• Mitochondria are crucial for cellular energy and are implicated in various diseases.
• Developing targeted CPPs for mitochondria can enhance therapeutic strategies.

Purpose of the Study:

• To synthesize and characterize novel, small cell-penetrating peptides (CPPs) that specifically target mitochondria.
• To evaluate the efficacy of these peptides in influencing intramitochondrial processes and improving biological effects.
• To assess the safety and cellular uptake of the novel CPPs.

Main Methods:

• Manual synthesis of novel CPPs using 9-fluorenylmethyloxycarbonyl chemistry.
• In vitro studies using HeLa 705, U87, and bEnd.3 cells to assess cell viability and proliferation.
• Evaluation of mitochondrial membrane potential and antioxidant activity, with H2O2 as a positive control.
• Fluorescent microscopy with FAM-conjugated peptides to determine cellular uptake and localization.
• Studies on isolated mitochondria to confirm targeting ability.

Main Results:

• Microscopy confirmed peptide penetration into cells, with a 35% increase in uptake for the novel peptide compared to SS-31.
• Mitochondrial CPP 1 (mtCPP-1) demonstrated significant protection against reactive oxygen species formation (2-fold increase compared to SS-31) in bEnd.3 cells.
• No cytotoxicity was observed, even at high concentrations (100 µM).

Conclusions:

• The novel peptide mtCPP-1 functions as a mitochondrial CPP.
• mtCPP-1 effectively protects mitochondria from oxidative damage through its inherent antioxidant activities.
• These findings suggest mtCPP-1 as a promising candidate for mitochondrial-targeted therapies with a favorable safety profile.